22 - Biogen: The neuro-focused biotech is making an undisclosed number of cuts to its research team as it prioritizes ... 10 - Intellia Therapeutics: Exactly one year after slashing 15% of its ...
Here are some of the best strategies that can help you lead your biotech team to success. One of the first steps to ensure project completion on time is to define the goals and scope of your ...
BioSpace Senior Editor Annalee Armstrong headed to the J.P. Morgan Healthcare Conference with a months-long story idea ...
4 天on MSN
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...
Andreas Föller outlines the different management skills needed by growing biotechnology companies. The founder of a successful public biotechnology company once told me that the secret to his ...
Diag-Nose.io hopes to transform management of chronic respiratory diseases globally using its AI-powered biomarker diagnostic ...
Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...
There’s a shopping bonanza for new obesity medicines going on among a marquee cohort of biopharma investors who are in-licensing treatment candidates from Chi ...
The Motley Fool on MSN15 天
This Biotech Stock Soared 116% in 2024, but Is It a Buy in 2025?One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs that's proven to be both efficacious and safe in clinical studies and in ...
Y Combinator's Surbhi Sarna has raised $30 million for Collate, a startup aiming to automate the tedious parts of running a life sciences business using AI.
Keep up with biotech layoffs in 2025! Each week, the Labiotech team tracks and analyzes layoffs across the biotech industry, offering a clear, data-driven view of trends affecting companies, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果